UnknownNCT03353597
Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects
PHASE1 · PHASE2 · 2,120 planned enrolment
- Countries listed
- 1
- Registry update
- January 17, 2018
immortal.lifePublic trial registrations naming Chandra Duggirala as an industry lead sponsor.
This is an independent registry-name view, not a verified corporate profile, portfolio valuation, ownership map, endorsement, or investment recommendation.
This does not mean that no transaction exists. A record appears only after its disclosure source and the connection to this exact registry sponsor identity are separately verified.
PHASE1 · PHASE2 · 2,120 planned enrolment